Avai Bio (AVAI) Change in Accured Expenses (2020 - 2023)

Avai Bio has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $440000.0 for Q4 2023.

• In Q4 2023, Change in Accured Expenses rose 1034.75% year-over-year to $440000.0; the TTM figure through Dec 2023 stood at $647309.0 (up 196.56% YoY), while the FY2023 annual figure was -$2816.0, down 102.33% from the prior year.
• Change in Accured Expenses came in at $440000.0 for Q4 2023 at Avai Bio, up from -$48600.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $440000.0 in Q4 2023 to a low of -$101646.0 in Q3 2021.
• Average Change in Accured Expenses over 4 years is $53619.3, with a median of $13515.5 recorded in 2020.
• The largest YoY upside for Change in Accured Expenses was 8073.33% in 2021 against a maximum downside of 1629.66% in 2021.
• Over 4 years, Change in Accured Expenses stood at $17260.0 in 2020, then plunged by 226.55% to -$21842.0 in 2021, then soared by 277.52% to $38775.0 in 2022, then soared by 1034.75% to $440000.0 in 2023.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $440000.0 in Q4 2023, -$48600.0 in Q3 2023, and $266000.0 in Q2 2023.